Company: OSRH
Filing Date: 2025-01-10
Form Type: 8-K
Source: 0001193125-25-004439
Chunk: 1

Company: OSR Holdings, Inc.
Filing Date: 2025-01-10
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01.      Financial Statements and Exhibits.  

(d) Exhibits.

  Exhibit      Description                                                                                                                                              
      No.                                                                                                                                                               
     10.1      Amendment to Promissory Notes, dated January 9, 2025, between Bellevue Life Sciences Acquisition Corp. and Bellevue Global Life Sciences Investors, LLC  
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
      104      Cover Page Interactive Data File (embedded within the Inline XBRL document)                                                                              

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: January 10, 2025

  BELLEVUE LIFE SCIENCES ACQUISITION CORP.                               
  By:                                           /s/ Kuk Hyoun Hwang      
  Name:                                         Kuk Hyoun Hwang          
  Title:                                        Chief Executive Officer